205 related articles for article (PubMed ID: 18728158)
1. Estradiol supplementation in postmenopausal women attenuates suppression of pulsatile growth hormone secretion by recombinant human insulin-like growth factor type I.
Veldhuis JD; Keenan DM; Bailey JN; Adeniji A; Miles JM; Paulo R; Cosma M; Soares-Welch C
J Clin Endocrinol Metab; 2008 Nov; 93(11):4471-8. PubMed ID: 18728158
[TBL] [Abstract][Full Text] [Related]
2. Short-term estradiol replacement in postmenopausal women selectively mutes somatostatin's dose-dependent inhibition of fasting growth hormone secretion.
Bray MJ; Vick TM; Shah N; Anderson SM; Rice LW; Iranmanesh A; Evans WS; Veldhuis JD
J Clin Endocrinol Metab; 2001 Jul; 86(7):3143-9. PubMed ID: 11443179
[TBL] [Abstract][Full Text] [Related]
3. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
[TBL] [Abstract][Full Text] [Related]
4. Testosterone supplementation in older men restrains insulin-like growth factor's dose-dependent feedback inhibition of pulsatile growth hormone secretion.
Veldhuis JD; Keenan DM; Bailey JN; Adeniji A; Miles JM; Paulo R; Cosma M; Soares-Welch C
J Clin Endocrinol Metab; 2009 Jan; 94(1):246-54. PubMed ID: 18984660
[TBL] [Abstract][Full Text] [Related]
5. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
Veldhuis JD; Evans WS; Bowers CY
J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
[TBL] [Abstract][Full Text] [Related]
6. Actions of estrogen on pulsatile, nyctohemeral, and entropic modes of growth hormone secretion.
Shah N; Evans WS; Veldhuis JD
Am J Physiol; 1999 May; 276(5):R1351-8. PubMed ID: 10233027
[TBL] [Abstract][Full Text] [Related]
7. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
[TBL] [Abstract][Full Text] [Related]
8. Estradiol supplementation modulates growth hormone (GH) secretory-burst waveform and recombinant human insulin-like growth factor-I-enforced suppression of endogenously driven GH release in postmenopausal women.
Veldhuis JD; Anderson SM; Kok P; Iranmanesh A; Frystyk J; Ørskov H; Keenan DM
J Clin Endocrinol Metab; 2004 Mar; 89(3):1312-8. PubMed ID: 15001627
[TBL] [Abstract][Full Text] [Related]
9. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women.
Veldhuis JD; Keenan DM; Iranmanesh A; Mielke K; Miles JM; Bowers CY
J Clin Endocrinol Metab; 2006 Sep; 91(9):3559-65. PubMed ID: 16804038
[TBL] [Abstract][Full Text] [Related]
10. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women.
Kok P; Paulo RC; Cosma M; Mielke KL; Miles JM; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2008 Oct; 93(10):4020-6. PubMed ID: 18611978
[TBL] [Abstract][Full Text] [Related]
11. Tripartite neuroendocrine activation of the human growth hormone (GH) axis in women by continuous 24-hour GH-releasing peptide infusion: pulsatile, entropic, and nyctohemeral mechanisms.
Shah N; Evans WS; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 1999 Jun; 84(6):2140-50. PubMed ID: 10372723
[TBL] [Abstract][Full Text] [Related]
12. Lowering total plasma insulin-like growth factor I concentrations by way of a novel, potent, and selective growth hormone (GH) receptor antagonist, pegvisomant (B2036-peg), augments the amplitude of GH secretory bursts and elevates basal/nonpulsatile GH release in healthy women and men.
Veldhuis JD; Bidlingmaier M; Anderson SM; Wu Z; Strasburger CJ
J Clin Endocrinol Metab; 2001 Jul; 86(7):3304-10. PubMed ID: 11443205
[TBL] [Abstract][Full Text] [Related]
13. Estradiol supplementation in postmenopausal women doubles rebound-like release of growth hormone (GH) triggered by sequential infusion and withdrawal of somatostatin: evidence that estrogen facilitates endogenous GH-releasing hormone drive.
Veldhuis JD; Anderson SM; Patrie JT; Bowers CY
J Clin Endocrinol Metab; 2004 Jan; 89(1):121-7. PubMed ID: 14715838
[TBL] [Abstract][Full Text] [Related]
14. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women.
Weissberger AJ; Ho KK; Lazarus L
J Clin Endocrinol Metab; 1991 Feb; 72(2):374-81. PubMed ID: 1991807
[TBL] [Abstract][Full Text] [Related]
15. Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women.
Anderson SM; Shah N; Evans WS; Patrie JT; Bowers CY; Veldhuis JD
J Clin Endocrinol Metab; 2001 Feb; 86(2):551-60. PubMed ID: 11158008
[TBL] [Abstract][Full Text] [Related]
16. Both oral and transdermal estrogen increase growth hormone release in postmenopausal women--a clinical research center study.
Friend KE; Hartman ML; Pezzoli SS; Clasey JL; Thorner MO
J Clin Endocrinol Metab; 1996 Jun; 81(6):2250-6. PubMed ID: 8964860
[TBL] [Abstract][Full Text] [Related]
17. Increased pulsatile, but not basal, growth hormone secretion rates and plasma insulin-like growth factor I levels during the periovulatory interval in normal women.
Ovesen P; Vahl N; Fisker S; Veldhuis JD; Christiansen JS; Jørgensen JO
J Clin Endocrinol Metab; 1998 May; 83(5):1662-7. PubMed ID: 9589674
[TBL] [Abstract][Full Text] [Related]
18. Fasting suppresses pulsatile luteinizing hormone (LH) secretion and enhances orderliness of LH release in young but not older men.
Bergendahl M; Aloi JA; Iranmanesh A; Mulligan TM; Veldhuis JD
J Clin Endocrinol Metab; 1998 Jun; 83(6):1967-75. PubMed ID: 9626127
[TBL] [Abstract][Full Text] [Related]
19. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in anorexia nervosa.
Gianotti L; Pincelli AI; Scacchi M; Rolla M; Bellitti D; Arvat E; Lanfranco F; Torsello A; Ghigo E; Cavagnini F; Müller EE
J Clin Endocrinol Metab; 2000 Aug; 85(8):2805-9. PubMed ID: 10946886
[TBL] [Abstract][Full Text] [Related]
20. Short-term testosterone supplementation does not activate GH and IGF-I production in postmenopausal women.
Soares-Welch C; Mielke KL; Bowers CY; Veldhuis JD
Clin Endocrinol (Oxf); 2005 Jul; 63(1):32-8. PubMed ID: 15963058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
